Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

ITK inhibitors may effectively treat alopecia areata.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Gefitinib can cause rare scarring hair loss.

A new dissolving microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Cetuximab can cause skin cysts after acne-like eruptions.

Gefitinib can cause hair and eyebrow darkening.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.